Published by The Medical Letter, Inc. • 1000 Main Street, New Rochelle, N.Y. 10801 • A Nonprofit Publication

   options

 

Select a Newsletter:
Select a year:
ONLINE ARCHIVES - The Medical Letter on Drugs and Therapeutics
These online issues of The Medical Letter are only accessible by registered online subscribers of The Medical Letter. Reading these articles requires Adobe Acrobat Reader.

For Non-Subscribers:
Subscribe online now and receive immediate online access
Purchase any single issue
The Medical Letter on Drugs and Therapeutics - 2008
January February
January 14; 50 (1277) : 1-4
A Diclofenac Patch (Flector) for Pain;
Two New Drugs for HIV Infection;
In Brief: Cetirizine OTC
January 28; 50 (1278) : 5-8
Doripenem (Doribax) — A New Parenteral Carbapenem;
Ixabepilone (Ixempra) for Breast Cancer;
In Brief: Zetia and Vytorin: The ENHANCE Study
February 11; 50 (1279) : 9-12
Budesonide/Formoterol (Symbicort) for Asthma;
Ophthalmic Azithromycin (AzaSite);
In Brief: Herbal Warning
February 25; 50 (1280) : 13-16
Retapamulin (Altabax) — A New Topical Antibiotic;
Veregen: A Botanical for Treatment of Genital Warts;
In Brief: Sevelamer-Based Phosphate Binders
March April
March 10; 50 (1281) : 17-20
Nebivolol (Bystolic) for Hypertension;
Gluten-Free Drugs for Celiac Disease Patients
March 24; 50 (1282) : 21-24
A Rivastigmine Patch for Dementia;
Palatal Implants for Snoring and Obstructive Sleep Apnea;
In Brief: Influenza Developments
April 7; 50 (1283) : 25-28
Simcor: A Niacin/Simvastatin Combination;
Nilotinib (Tasigna) for CML;
Tadalafil (Cialis) Once a Day for Erectile Dysfunction;
In Brief: Meningococcal Prophylaxis
April 21; 50 (1284) : 29-32
Which Statin?;
Diclofenac Gel for Osteoarthritis;
In Brief: Genetic Test for Carbamazepine-Induced Stevens-Johnson Syndrome
May June
May 5; 50 (1285) : 33-36
Ciclesonide (Omnaris) for Allergic Rhinitis;
Natalizumab (Tysabri) for Crohn's Disease;
In Brief: A New Indication for Colesevelam (Welchol)
May 19; 50 (1286) : 37-40
Desvenlafaxine for Depression;
Pharmacogenetic-Based Dosing of Warfarin;
In Brief: IV Artesunate for Severe Malaria
June 2; 50 (1287) : 41-44
Spinal Decompression Machines;
Bevacizumab (Avastin) for Metastatic Breast Cancer;
Sapropterin (Kuvan) for Phenylketonuria;
In Brief: Measles Outbreak;
Correction: Natalizumab (Tysabri) for Crohn’s Disease
June 16; 50 (1288) : 45-48
A Fixed-Dose Combination of Sumatriptan and Naproxen for Migraine;
Vitamins for Cataract Prevention;
Etravirine (Intelence) for HIV Infection;
Addendum: Warfarin-Acetaminophen Interaction
June 30 ; 50 (1289) : 49-52
Finasteride for Prevention of Prostate Cancer;
Extended-Release Fluvoxamine (Luvox CR);
Olopatadine (Patanase) Nasal Spray;
In Brief: Intensive Glucose Lowering in Type 2 Diabetes
July August
July 14; 50 (1290) : 53-56
Varenicline (Chantix) Warnings: Risk Versus Benefit;
Lubiprostone (Amitiza) for Irritable Bowel Syndrome with Constipation;
Wellbutrin Versus Generic Bupropion;
The EarCheck Middle Ear Monitor for Detection of Middle Ear Effusion in Children
July 28; 50 (1291) : 57-60
Duloxetine (Cymbalta) for Fibromyalgia;
Drugs for Travelers' Diarrhea;
ECGs Before Stimulants in Children;
A Reminder: Meningococcal Vaccine
August 11; 50 (1291) : 61-64
Antiplatelet Therapy for Patients with Stents;
Methylnaltrexone (Relistor) for Opioid-Induced Constipation;
Correction: The EarCheck Middle Ear Monitor
 
 
 
September October
 
 
 
 
 
 
 
 
 
 
 
 
 
 
November December
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Subscribe online now and receive immediate online access
 
© 2008 The Medical Letter, Inc. All rights reserved. Use of this site signifies your agreement to the Terms and Conditions.